Kristopher Sturgis is a freelance contributor to MD+DI.
The new system, known as SOZO, aids in the clinical assessment of bilateral lymphedema in adult cancer patients by identifying those at risk.
The developer of precision vascular robotics announced its CorPath GRX System was successfully used in robotic-assisted coronary interventions.
An industry expert shares how emerging micro and nanotechnologies could shape the next generation of implantable drug-delivery systems.
Daxor’s new technology designed to measure blood volume has the potential to reduce patient readmission rates and improve outcomes for patients suffering from acute heart failure.
A startup spawned from Oxford University is trying to commercialize components of a quantum computing technology that could ultimately improve the downstream end of existing diagnostic devices.
Using the latest in virtual and augmented reality technology, an award winning medical technology company is creating lifelike video game simulations to help train physicians and improve diagnosis and treatment methods.
The company has launched the ‘Relay robot,’ a new autonomous service robot designed to optimize labor productivity in hospital lab environments.
A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.
A new competition that aims to develop innovative and sustainable ideas for injection medicine has awarded a development contract to the winner for a novel documentation process for drug administration.
Thanks to a new validation and part process, molders can now replicate transferable plastic conditions that can save millions of dollars a year and reduce machine downtime.
Even though plastic is easy to use, cost effective, and well established, medtech engineers can run into challenges.
BeBop Sensors is developing a new line of sensor technologies aimed at powering new wearable devices and smart fabrics.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.